Frank Vanderdonck

Frank Vanderdonck is a seasoned professional with extensive experience in medical affairs, regulatory strategy, and business intelligence within the pharmaceutical industry. Currently serving as a Medical Affairs Consultant and Managing Partner at AxTalis since January 2020, Frank specializes in translating registration and access into launch strategies across the BeNeLux Nordics region. Previous roles include leadership positions at Avivia, Sandoz, Novartis, Chamaeleo Pharma, Ipsen, and UCB Pharma, where contributions ranged from project management and market access to competitive intelligence and medical education strategy. Frank holds a Master of Pharmaceutical Sciences from Ghent University and has a strong track record of driving growth, improving operational efficiencies, and enhancing the effectiveness of medical affairs teams.